PHARMAORIGIN ApS: Financial statements 2020
CVR: 29178291
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
PHARMAORIGIN ApS (CVR 29178291) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK 13,000 compared with DKK 18,000 the year before. Equity in the 2020 report amounted to DKK 1,108,000. The solvency ratio was 99.1%.
- Profit/Loss
- DKK 13,000
- Equity
- DKK 1,108,000
- Total Assets
- DKK 1,118,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | - | 13 t. | 1.1 mio. | - |
| 2019 | - | - | 18 t. | 1.1 mio. | 0 |
| 2018 | - | - | -23 t. | 1.1 mio. | - |
| 2017 | - | - | -4.3 mio. | 1.1 mio. | - |
| 2016 | - | - | -1.7 mio. | 5.4 mio. | - |
How creditworthy is PHARMAORIGIN ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of September 11, 2020, Robert Norman Neville has stepped down as director of PHARMAORIGIN ApS.
PHARMAORIGIN ApS has published its annual report for 2019. The net result was DKK 18,000.
About PHARMAORIGIN ApS
PHARMAORIGIN ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named ApS KBUS 17 NR. 4503. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. The company has 0 employees (2008). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity in the 2025 report amounted to DKK 1,477,000.